SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Amos K.)
 

Sökning: WFRF:(Amos K.) > Obesity, metabolic ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00009578naa a2201129 4500
001oai:DiVA.org:umu-137383
003SwePub
008170706s2017 | |||||||||||000 ||eng|
009oai:lup.lub.lu.se:c57d2208-8a7c-4b90-a329-db261e03f196
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1373832 URI
024a https://doi.org/10.1371/journal.pone.01778752 DOI
024a https://lup.lub.lu.se/record/c57d2208-8a7c-4b90-a329-db261e03f1962 URI
040 a (SwePub)umud (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Carreras-Torres, Robertu International Agency for Research on Cancer, World Health Organization4 aut
2451 0a Obesity, metabolic factors and risk of different histological types of lung cancer :b a Mendelian randomization study
264 c 2017-06-08
264 1b Public library science,c 2017
338 a electronic2 rdacarrier
520 a Background: Assessing the relationship between lung cancer and metabolic conditions is challenging because of the confounding effect of tobacco. Mendelian randomization (MR), or the use of genetic instrumental variables to assess causality, may help to identify the metabolic drivers of lung cancer. Methods and findings: We identified genetic instruments for potential metabolic risk factors and evaluated these in relation to risk using 29,266 lung cancer cases (including 11,273 adenocarcinomas, 7,426 squamous cell and 2,664 small cell cases) and 56,450 controls. The MR risk analysis suggested a causal effect of body mass index (BMI) on lung cancer risk for two of the three major histological subtypes, with evidence of a risk increase for squamous cell carcinoma (odds ratio (OR) [95% confidence interval (CI)] = 1.20 [1.01-1.43] and for small cell lung cancer (OR [95% CI] = 1.52 [1.15-2.00]) for each standard deviation (SD) increase in BMI [4.6 kg/m(2)]), but not for adenocarcinoma (OR [95% CI] = 0.93 [0.79-1.08]) (P-heterogeneity = 4.3x10(-3)). Additional analysis using a genetic instrument for BMI showed that each SD increase in BMI increased cigarette consumption by 1.27 cigarettes per day (P = 2.1x10(-3)), providing novel evidence that a genetic susceptibility to obesity influences smoking patterns. There was also evidence that low-density lipoprotein cholesterol was inversely associated with lung cancer overall risk (OR [95% CI] = 0.90 [0.84-0.97] per SD of 38 mg/dl), while fasting insulin was positively associated (OR [95% CI] = 1.63 [1.25-2.13] per SD of 44.4 pmol/l). Sensitivity analyses including a weighted-median approach and MR-Egger test did not detect other pleiotropic effects biasing the main results. Conclusions: Our results are consistent with a causal role of fasting insulin and low-density lipoprotein cholesterol in lung cancer etiology, as well as for BMI in squamous cell and small cell carcinoma. The latter relation may be mediated by a previously unrecognized effect of obesity on smoking behavior.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
700a Johansson, Mattiasu International Agency for Research on Cancer, World Health Organization4 aut
700a Haycock, Philip C.u University of Bristol,Fred Hutchinson Cancer Research Center4 aut
700a Wade, Kaitlin H.u University of Bristol4 aut
700a Relton, Caroline L.u University of Bristol4 aut
700a Martin, Richard M.u University of Bristol4 aut
700a Smith, George Daveyu University of Bristol4 aut
700a Albanes, Demetriusu National Cancer Institute, USA4 aut
700a Aldrich, Melinda C.u Vanderbilt University4 aut
700a Andrew, Angelineu Norris Cotton Cancer Center,Dartmouth College,University of Liverpool,Radboud University Medical Center4 aut
700a Arnold, Susanne M.u University of Kentucky4 aut
700a Bickeböller, Heikeu University of Göttingen4 aut
700a Bojesen, Stig E.u University of Copenhagen4 aut
700a Brunnström, Hansu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Regional Laboratories Region Skåne4 aut0 (Swepub:lu)med-hsb
700a Manjer, Jonasu Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups,Regional Laboratories Region Skåne4 aut0 (Swepub:lu)smi-jma
700a Brüske, Ireneu Helmholtz Zentrum München4 aut
700a Caporaso, Neil E.u National Cancer Institute, NCI4 aut
700a Chen, Chuu Harvard T.H. Chan School of Public Health,Harvard Medical School4 aut
700a Christiani, David C.4 aut
700a Christian, W. Jayu University of Kentucky4 aut
700a Doherty, Jennifer A.4 aut
700a Duell, Eric J.u Catalan Institute of Oncology4 aut
700a Field, John K.u University of Liverpool4 aut
700a Davies, Michael P. A.4 aut
700a Marcus, Michael W.u University of Liverpool4 aut
700a Goodman, Gary E.u Fred Hutchinson Cancer Research Center4 aut
700a Grankvist, Kjellu Umeå University,Umeå universitet,Klinisk kemi4 aut0 (Swepub:umu)kjgr0002
700a Haugen, Aageu National Institute of Occupational Health, Norway4 aut
700a Hong, Yun-Chulu Seoul National University4 aut
700a Kiemeney, Lambertus A.4 aut
700a van der Heijden, Erik H. F. M.u Radboud University Medical Center4 aut
700a Kraft, Peteru Harvard T.H. Chan School of Public Health4 aut
700a Johansson, Mikael B.u Umeå University,Umeå universitet,Onkologi4 aut0 (Swepub:umu)mijo0025
700a Lam, Stephenu British Columbia Cancer Agency4 aut
700a Landi, Maria Teresau National Cancer Institute, USA4 aut
700a Lazarus, Philipu Washington State University College of Pharmacy4 aut
700a Le Marchand, Loïcu University of Hawaii Cancer Center4 aut
700a Liu, Geoffreyu Princess Margaret Hospital University of Toronto4 aut
700a Melander, Olleu Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Department of Clinical Sciences, Malmö,Faculty of Medicine,Cardiovascular Research - Hypertension,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)endo-ome
700a Park, Sungshim L.u University of Southern California4 aut
700a Rennert, Gadu Technion - Israel Institute of Technology4 aut
700a Risch, Angelau University of Salzburg4 aut
700a Haura, Eric B.u H. Lee Moffitt Cancer Center & Research Institute4 aut
700a Scelo, Ghislaineu International Agency for Research on Cancer, World Health Organization4 aut
700a Zaridze, Davidu N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences4 aut
700a Mukeriya, Anushu N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences4 aut
700a Savić, Milanu Clinical Center of Serbia4 aut
700a Lissowska, Jolantau The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology4 aut
700a Swiatkowska, Beatau Nofer Institute of Occupational Medicine4 aut
700a Janout, Vladimiru University of Ostrava4 aut
700a Holcatova, Ivanau Charles University in Prague4 aut
700a Mates, Danau National Institute of Public Health, Romania4 aut
700a Schabath, Matthew B.u H. Lee Moffitt Cancer Center & Research Institute4 aut
700a Shen, Hongbingu Nanjing Medical University4 aut
700a Tardon, Adoninau University of Oviedo4 aut
700a Teare, Dawnu University of Sheffield4 aut
700a Woll, Penellau University of Sheffield4 aut
700a Tsao, Ming-Soundu Princess Margaret Hospital University of Toronto4 aut
700a Wu, Xifengu University of Texas4 aut
700a Yuan, Jian-Minu University of Pittsburgh Cancer Institute4 aut
700a Hung, Rayjean J.u Mount Sinai Hospital of University of Toronto4 aut
700a Amos, Christopher I.u Dartmouth College4 aut
700a McKay, Jamesu International Agency for Research on Cancer, World Health Organization4 aut
700a Brennan, Paulu International Agency for Research on Cancer, World Health Organization4 aut
710a International Agency for Research on Cancer, World Health Organizationb University of Bristol4 org
773t PLOS ONEd : Public library scienceg 12:6q 12:6x 1932-6203
856u https://doi.org/10.1371/journal.pone.0177875y Fulltext
856u https://umu.diva-portal.org/smash/get/diva2:1120595/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856u https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0177875&type=printable
856u http://dx.doi.org/10.1371/journal.pone.0177875x freey FULLTEXT
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-137383
8564 8u https://doi.org/10.1371/journal.pone.0177875
8564 8u https://lup.lub.lu.se/record/c57d2208-8a7c-4b90-a329-db261e03f196

Hitta via bibliotek

  • PLOS ONE (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy